Harmony Biosciences

Harmony Biosciences is a biopharmaceutical company headquartered in Pennsylvania, founded in October 2017. It is dedicated to providing new treatment options for people with rare orphan diseases. The company's key research and development focus is on central nervous system disorders. Its main product is a drug called Pitolisant, primarily used to treat narcolepsy.